Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03804216
Other study ID # OCTADIAL
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 1, 2019
Est. completion date June 1, 2020

Study information

Verified date July 2020
Source Centre Hospitalier Intercommunal Creteil
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Little knowledge exist on the short and long-term ophthalmological effect of the dialysis. Some studies stated a variation of the thickness subfoveal choroidal before and after a session of dialyse as well as variations of the coat of optical fibers measured in OCT.

The Optical Coherence Tomography angiography OCT is a not invasive imaging technique which is now a part of examinations of investigation in imaging of retina. This technique allows to study the retinal macula vascularization without injection of contrast agent and thus allows to deepen the knowledge in medical domains where the exploration was to limited because of the invasive character of the examinations.

The hypothesis of this project is that hemodynamic change during the hemodialysis may lead fine variations of the retinal vascularization in the short-term (the day of the dialysis) but also in the longer term (over 1 year).


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date June 1, 2020
Est. primary completion date February 26, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Indication of treatment by hemodialysis

- First session of dialysis

- Hemodialysis planned for 1 minimum year

Exclusion Criteria:

- particular ophthalmological Histories: vitreo-retinal surgery, strong nearsightedness, chronic glaucoma

- Unaffiliated in a national insurance scheme

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Multimodal Imaging Analysis
The patients are seen in consultation ophthalmological before and the 1 hour after their session of dialysis. THE OCT angiography and other not invasive ophthalmological examinations will be realized during the follow-up

Locations

Country Name City State
France Ophtalmology department Creteil

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Intercommunal Creteil

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary vascular density before hemodialysis Analysis of the variation of the vascular densities in retinal macula in the central 6 mm before hemodialysis
Primary vascular density 1 hour after hemodialysis Analysis of the variation of the vascular densities in retinal macula in the central 6 mm 1 hour after hemodialysis
Secondary vascular density 1 month after dialysis Analysis of the variation of the vascular densities in retinal macula in the central 6 mm 1 month after dialysis
Secondary vascular density 3 month after dialysis Analysis of the variation of the vascular densities in retinal macula in the central 6 mm 3 month after dialysis
Secondary vascular density 6 month after dialysis Analysis of the variation of the vascular densities in retinal macula in the central 6 mm 6 month after dialysis
Secondary vascular density 12 month after dialysis Analysis of the variation of the vascular densities in retinal macula in the central 6 mm 12 month after dialysis
Secondary vascular density before dialysis mesure by OCTA before dialysis
Secondary vascular density 1 hour after dialysis mesure by OCTA 1 hour after dialysis
Secondary vascular density 1 month after dialysis mesure by OCTA 1 month after dialysis
Secondary vascular density 3 month after dialysis mesure by OCTA 3 month after dialysis
Secondary vascular density 6 month after dialysis mesure by OCTA 6 month after dialysis
Secondary vascular density 12 month after dialysis mesure by OCTA 12 month after dialysis
Secondary size of coat retinal optical fibers before dialysis variation of the coat before dialysis
Secondary size of coat retinal optical fibers 1 hour after dialysis variation of the coat 1 hour after dialysis
Secondary size of coat retinal optical fibers 1 month after dialysis variation of the coat 1 month after dialysis
Secondary size of coat retinal optical fibers 3 month after dialysis variation of the coat 3 month after dialysis
Secondary size of coat retinal optical fibers 6 month after dialysis variation of the coat 6 month after dialysis
Secondary size of coat retinal optical fibers 12 month after dialysis variation of the coat 12 month after dialysis
See also
  Status Clinical Trial Phase
Completed NCT02763410 - Impact of the Composition of Packed Red Blood Cell Supernatant on Renal Dysfunction and Posttransfusion Immunomodulation
Active, not recruiting NCT03183245 - Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis Phase 3
Completed NCT04084301 - Impact of Cardiopulmonary Bypass Flow on Renal Oxygenation, Blood Flow and Tubular Injury N/A
Completed NCT03292029 - Pilot Medical Evaluation of the T50 Test N/A
Suspended NCT04589065 - SCD for CRS in Congestive Heart Failure (CHF) (No Left Ventricular Assist Device) N/A
Completed NCT03806998 - Effects of a Ketoacid Supplementation in Patients With Stage III to IV Renal Failure Phase 3
Active, not recruiting NCT03672110 - Slow and Low Start of a Tacrolimus Once Daily Immunosuppressive Regimen Phase 3
Completed NCT02325726 - RRI Compared With NephroCheckTM to Predict Acute Renal Failure After Cardiac Surgery. N/A
Completed NCT02116270 - Accelerated Immunosenescence and Chronic Kidney Disease N/A
Completed NCT01859273 - Adherence Enhancement for Renal Transplant Patients N/A
Completed NCT01388270 - Effect of a Pre Heparin Coated Dialysis Filter on Coagulation During Hemodialysis Phase 4
Completed NCT01187953 - Double-Blind,Double-Dummy,Efficacy/Safety,LCP-Tacroâ„¢ Vs Prograf®,Prevention Rejection,De Novo Adult Kidney Tx Phase 3
Completed NCT01476995 - Prognostic Indicators as Provided by the EPIC ClearView N/A
Completed NCT00966615 - The Effect of Neutral Peritoneal Dialysis (PD) Solution With Minimal Glucose-Degradation-Product (GDP) on Fluid Status and Body Composition Phase 4
Completed NCT01008631 - The Pharmacologic Profile of Sodium Thiosulfate in Renal Failure and Healthy Volunteers N/A
Completed NCT00765661 - Pharmacokinetics of LCP-Tacro(TM) Once Daily And Prograf® Twice A Day in Adult De Novo Kidney Transplant Patients Phase 2
Completed NCT00737672 - GORE VIABAHN Endoprosthesis Versus Percutaneous Transluminal Angioplasty (PTA) to Revise AV Grafts in Hemodialysis Phase 3
Completed NCT00808691 - Microcirculation and Oxidative Stress in Critical Ill Patients in Surgical Intensive Care Unit N/A
Recruiting NCT00470769 - The Efficacy of Color-Doppler Ultrasonography to Assess the Renal Blood Flow With the Estimation of GFR N/A
Terminated NCT00338455 - Natrecor (Nesiritide) in Transplant-Eligible Management of Congestive Heart Failure-TMAC Phase 2